Effect of NSAIDs on risk of Alzheimer's disease: confounding factors were not discussed

Comment

Michael Robertson. BMJ. 2003.

. 2003 Sep 27;327(7417):751; author reply 751-2.

doi: 10.1136/bmj.327.7417.751-b.

No abstract available

Comment on

Data dredging, bias, or confounding.
Smith GD, Ebrahim S. Smith GD, et al. BMJ. 2002 Dec 21;325(7378):1437-8. doi: 10.1136/bmj.325.7378.1437. BMJ. 2002. PMID: 12493654 Free PMC article. No abstract available.
Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.
Etminan M, Gill S, Samii A. Etminan M, et al. BMJ. 2003 Jul 19;327(7407):128. doi: 10.1136/bmj.327.7407.128. BMJ. 2003. PMID: 12869452 Free PMC article.

1. Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 2003;327: 128-31. (19 July.) - PMC - PubMed
1. Davey Smith G, Ebrahim S. Data dredging, bias, or confounding. BMJ 2002;325: 1437-8. - PMC - PubMed
1. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 2003;289: 2819-26. - PubMed